...lead for inflammation at Amgen Inc. (NASDAQ:AMGN). Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) hired Gad...

...α-synuclein. MeiraGTx Holdings plc (NASDAQ:MGTX) has conducted Phase II testing of AAV-GAD, which delivers the GAD...
...chronic pain that are in preclinical testing. Targets: DDC (AADC) - Dopa decarboxylase; GAD - Glutamic acid decarboxylase...

...includes two candidates in Phase I/II testing: radiation-induced xerostomia therapy AAV-AQP1 and Parkinson's disease candidate AAV-GAD...
...Management also participated in the placement. MeiraGTx Holdings plc (NASDAQ:MGTX), New York, N.Y. Elizabeth S. Eaton AAV-AQP1 (A00X) AAV-GAD...

...includes two candidates in Phase I/II testing: radiation-induced xerostomia therapy AAV-AQP1 and Parkinson's disease candidate AAV-GAD...
...OrbiMed Advisors and 683 Capital Management also participated in the placement. Elizabeth S. Eaton AAV-AQP1 (A00X) AAV-CNGA3 (A003) AAV-CNGB3 (A002) AAV-GAD...

...α-synuclein. MeiraGTx Holdings plc (NASDAQ:MGTX) has conducted Phase II testing of AAV-GAD, which delivers the GAD...
...chronic pain that are in preclinical testing. Targets: DDC (AADC) - Dopa decarboxylase; GAD - Glutamic acid decarboxylase Mark...

...at NLS Pharma Group (Stans, Switzerland). Cellular metabolism company Rheos Medicines Inc. (Cambridge, Mass.) hired Gad...

...Cheung; Peter Bang; Sofinnova Partners; and founder, Chairman, President and Head of Business Development Thomas Gad...

...Cheung; Peter Bang; Sofinnova Partners; and founder, Chairman, President and Head of Business Development Thomas Gad...

...Depression Rating Scale (MADRS), patient-reported outcomes, clinical global impression of severity (CGI-S), Generalized Anxiety Disorder (GAD-7...

...applicable PUBLICATION DETAILS: Huang, Y. et al. Genes Dev. ; published online June 26, 2018 doi:10.1101/gad.314815.118...